Cafepharma Today

June 11 2025 - BMS expands radiopharma pipeline via RayzeBio's $1.3B prostate cancer drug deal
BMS expands radiopharma pipeline via RayzeBio's $1.3B prostate cancer drug deal
Novo Nordisk, Deep Apple launch drug discovery alliance for weight loss oral therapies
Eli Lilly works out $650M Juvena pact to find muscle-boosting drugs
Nvidia announces massive new initiatives in pharma and clinical research
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Sanofi Said to Join Bidders for Merck’s Consumer-Health Business
Bloomberg
Monday, March 24, 2014 - 6:21pm
tags:
Sanofi, Merck, M&A, consumer health
Sovaldi's Patent War
Seeking Alpha
Monday, March 24, 2014 - 6:00pm
tags:
Sovaldi, Gilead Sciences, hepatitis C, patents
IMS Health seeks valuation of up to $6.97 bln in IPO
Reuters
Monday, March 24, 2014 - 12:16pm
tags:
IPOs, IMS Health
U.S. top court takes no action in Teva MS drug case
Reuters
Monday, March 24, 2014 - 12:14pm
tags:
Teva Pharmaceuticals, MS, multiple sclerosis, generics, Copaxone
Novo CEO sees improved picture for Tresiba in U.S. market
Fierce Pharma
Monday, March 24, 2014 - 12:13pm
tags:
Novo Nordisk, Pharma CEOs, Tresiba, diabetes, Sanofi, insulin
Soriot notches a bigger bonus, but total $5.5M in pay is no record breaker
Fierce Pharma
Monday, March 24, 2014 - 12:11pm
tags:
Pascal Soriot, executive pay, AstraZeneca
Today’s Top Biotech Stories: Albany Molecular Research, Rockwell Medical, and Celgene
Motley Fool
Monday, March 24, 2014 - 12:07pm
tags:
Albany Molecular Research, Rockwell Medical, Celgene, Cedarburg Pharmaceuticals, Triferic, Otezla
Another Bad Day in Biotech Stocks, Pace of Selling Accelerates
TheStreet.com
Monday, March 24, 2014 - 12:04pm
tags:
biotech
JPMorgan Sees No Bubble, Hears No Bubble as Biotech Falls Again
Barron's
Monday, March 24, 2014 - 11:29am
tags:
biotech, Biogen Idec, Amgen, Celgene, Gilead Sciences, Regeneron
BioTime Joins Advanced Cell Technology In The AMD Race
Seeking Alpha
Monday, March 24, 2014 - 10:41am
tags:
BioTime, Advanced Cell Technology, age-related macular degeneration
Direct-To-Consumer Television Advertising Marks The Tipping Point For Belviq Sales
Seeking Alpha
Monday, March 24, 2014 - 10:01am
tags:
Belviq, obesity, Eisai, drug ads, Arena Pharmaceuticals
Cancer Vaccines: Doomed to Fail?
Motley Fool
Monday, March 24, 2014 - 10:01am
tags:
cancer vaccines, Vical, Merck KGaA, GSK, MAGE-A3, Dendreon, Provenge, Stimuvax
FDA says Exact Sciences colorectal cancer screening tool study met objectives
Yahoo/Fly on the Wall
Monday, March 24, 2014 - 9:58am
tags:
FDA, colorectal cancer, EXACT Sciences, Cologuard
Israel's BrainStorm gets U.S. patent for stem cell technology
Yahoo/Reuters
Monday, March 24, 2014 - 8:53am
tags:
stem cells, BrainStorm Cell Therapeutics, Israel, patents
One Of Pharma's Biggest Enemies Goes After The Future's Best-Selling Drug
Forbes
Monday, March 24, 2014 - 8:52am
tags:
drug pricing, Henry Waxman, Sovaldi, Gilead Sciences
Bristol-Myers, Roche, working on possible blockbusters for melanoma, WSJ says
Yahoo/Fly on the Wall
Monday, March 24, 2014 - 8:50am
tags:
Bristol-Myers Squibb, Roche, melanoma, AstraZeneca
The Use and Misuse of Information Technology in Health Care: Several Doctors Reply
Yahoo/The Atlantic
Monday, March 24, 2014 - 8:35am
tags:
EMRs, electronic medical records, physicians
Big pharma balks at investment in TB
Financial Times
Monday, March 24, 2014 - 8:33am
tags:
tuberculosis, R&D, AstraZeneca, JNJ
FDA says it is recalling twice the medical devices it did a decade ago
Marketwatch
Monday, March 24, 2014 - 8:31am
tags:
FDA, devices, recalls
Biotech Rival to Teva Blockbuster Said to Seek IPO
Bloomberg
Sunday, March 23, 2014 - 10:08am
tags:
Teva Pharmaceuticals, Mapi Pharma, Copaxone

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Novo Nordisk's Canadian Mistake
In the Pipeline
The Bethesda Declaration
In the Pipeline
Taurine and Aging: Is There Anything to It?
In the Pipeline
Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.